Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin

Abstract

AimTo explore the chronic effects of metformin on testosterone levels in men with type 2 diabetes mellitus (T2DM).MethodsThis is a secondary analysis of a real-world study evaluating the efficacy and safety of premixed insulin treatment in patients with T2DM via 3-month intermittent flash glucose monitoring. Male patients aged 18-60 who were using metformin during the 3-month study period were included as the metformin group. The control group included males without metformin therapy by propensity score matching analysis with age as a covariate. Testosterone levels were measured at baseline and after 3-month treatment.ResultsAfter 3-month treatment, the control group had higher levels of total testosterone, free and bioavailable testosterone than those at baseline (P<0.05). Compared with the control group, the change of total (-0.82 ± 0.59 vs. 0.99 ± 0.59 nmol/L) and bioavailable (-0.13 ± 0.16 vs. 0.36 ± 0.16 nmol/L) testosterone levels in the metformin group significantly decreased (P=0.036 and 0.029, respectively). In Glycated Albumin (GA) improved subgroup, the TT, FT, and Bio-T levels in the control subgroup were higher than their baseline levels (P < 0.05). Compared with the metformin subgroup, TT level in the control subgroup also increased significantly (P=0.044). In GA unimproved subgroup, the change of TT level in the metformin subgroup was significantly lower than that in the control subgroup (P=0.040).ConclusionIn men with T2DM, 3-month metformin therapy can reduce testosterone levels, and counteract the testosterone elevation that accompanied with the improvement of blood glucose.Clinical Trial Registrationhttps://www.clinicaltrials.gov/ct2/show/NCT04847219?term=04847219&draw=2&rank=1.

Metformin: Is it a drug for all reasons and diseases?

“…Metformin is used for the treatment of polycystic ovary syndrome (PCOS) with its benefits attributed to improving insulin sensitivity, reducing insulin levels and thereby reducing the activity of steroidogenic enzymes. Conversely, in males the use of metformin has been linked to genital defects in male offspring [36] that may be linked to reports of effects of metformin on human and mouse testicular cells, lowers testosterone levels, and also reports in fish that it is an endocrine disruptor [464][465][466][467][468][469] The effects of metformin on the microbiota in the gut where the release of GLP-1 from L-cells that in turn enhances the release of insulin from ß-cells in the pancreas. The anti-cancer effects of metformin have been attributed to the activation of AMPK and subsequent inhibition of mTOR.…”

Pituitary Effects of Metformin in Men With Early‐Onset Androgenic Alopecia

“…Previous clinical studies concentrated on the impact of metformin on testosterone concentration in men with low testosterone levels, providing contrasting results. Metformin administration reduced, 24,25 did not affect, 26 or increased 27 circulating levels of this hormone. However, participants of these studies markedly differed from subjects with increased androgen production.…”

Increased risk of testosterone deficiency is associated with the systemic immune-inflammation index: a population-based cohort study

“…Studies have shown that the use of metformin, a first-line glucose-lowering drug for the treatment of type 2 diabetes, also reduces serum testosterone levels in patients with diabetes ( 37 ). Patients with type 2 diabetes had significantly lower testosterone levels after three month of metformin treatment ( 42 ). So we think that drug use in patients with hypertension and diabetes may confuse the relationship between the SII and TD.…”